GlassScriptPhysician profile
Uttam Verma
NPI 1134502768
$4,770.30
in general payments reported to CMS, 2019-2025
16 companies · $1,321 in 2025
The $1,321 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $169 · 2021: $18.91 · 2022: $2,158 · 2024: $1,104 · 2025: $1,321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,239 · Travel and Lodging: $1,185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,239.41 |
| Travel and Lodging | $1,185.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Uk Limited | $2,157.88 | 2022 | |
| Microvention, INC. | $1,545.62 | 2024-2025 | Stent, Web Aneurysm Embolization System, Eric Retrieval Device |
| Medtronic, INC. | $261.11 | 2025 | Pipeline |
| Microtransponder, INC. | $157.35 | 2025 | |
| Stryker Corporation | $148.92 | 2025 | Surpass Evolve |
| Depuy Synthes Sales INC. | $148.40 | 2024 | Trufill |
| Penumbra, INC. | $133.66 | 2025 | Red 72 |
| Greenwich Biosciences, INC. | $50.43 | 2019 | |
| Chiesi USA, INC. | $34.21 | 2021-2025 | Cleviprex, Kengreal |
| Biogen, INC. | $29.25 | 2019 | |
| Allergan, INC. | $25.69 | 2019 | |
| Pfizer INC. | $17.51 | 2019 | |
| Amgen INC. | $16.44 | 2019 | |
| Avanir Pharmaceuticals, INC. | $15.45 | 2019 | |
| Integra Lifesciences Corporation | $14.54 | 2025 | Duraseal Exact Spinal Sealant System, Codman Certas, Cusa Clarity |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $13.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Uttam Verma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.